Zoekresultaten - 8 results

Utilization of gabapentin by people in treatment for substance use disorders in Belgium (2011-2014): a cross-sectional study.

gabapentin has been licensed in the European Union only for neuropathic pain and epilepsy for patients who have partial seizures, it has also been prescribed in treatment for substance use disorders. Many ...

Longitudinal pharmacoepidemiological and health services research for substance users in treatment: protocol of the Belgian TDI-IMA linkage.

known about the health seeking behavior of people with substance use disorders before they enter specialized treatment and afterwards. This paper explains in detail the protocol that has been followed to ...

Registration of treatment demands for substance use disorders in Belgium: Why are some clients registered anonymously?

Publication Type: Scientific poster, presentation or proceeding Authors: Jérôme Antoine; Françoise Renard Source: Lisbon Addictions 2017 (2017) Health Topics:  Illegale drugs Illicit drugs Drogues illégales Service:  Information sanitaire Gezondheidsinfor ...

L'enregistrement TDI en Belgique- Rapport annuel, année d'enregistrement 2015

illicit drugs substance use disorder TDI treatment Health Topics:  Surveillance de la santé et des maladies Health and disease monitoring Ziekten en gezondheid in kaart brengen Service:  Information ...

De TDI-registratie in België- Jaarlijks rapport, registratiejaar 2015

illicit drugs substance use disorder TDI treatment Health Topics:  Ziekten en gezondheid in kaart brengen Illegale drugs Health and disease monitoring Surveillance de la santé et des maladies Illicit drugs ...

General practice patients treated for substance use problems: a cross-national observational study in Belgium.

-Related Disorders Abstract: BACKGROUND: General Practitioners (GP s) are well placed to care for patients with (chronic) substance use problems. This pilot was carried out to study the feasibility and usefulness of ...

Treatment for substance use disorders: the Belgian Treatment Demand Indicator registration protocol.

BACKGROUND: Registration of patients with substance use disorders is of key importance to get insights and to study trends in patients characteristics and substance use patterns. The Treatment Demand Indicator ...

Diagnostic hepatitis C testing of people in treatment for substance use disorders in Belgium between 2011 and 2014: a cross-sectional study.

analysis is the result of a descriptive crosssectional study, based on data extracted from the linkage between a database of people in treatment for substance use disorders in Belgium and a database of the ...

QR code

QR code for this page URL